Read this on the list

[Guest guest]

I read this on the <mailto: > list

and thought this new discovery would be helpful to many of our viral kids.

Dr. Goldberg is in Reno this week for a meeting and conference with Dr.

Mikovits and others. The Nids list is a great source of info for Dr. G’s

protocol.

Best,

Marcia

</message/43874;_ylc=X3oDMTJxOWY4MDNrBF9TA

zk3MzU5NzE1BGdycElkAzEyODk0MARncnBzcElkAzE3MDUwNjE2MTYEbXNnSWQDNDM4NzQEc2VjA

2Rtc2cEc2xrA3Ztc2cEc3RpbWUDMTI4MjA1NTMzMA--> Findings by Reno scientists

confirmed by U.S. government

Posted by: " "

<mailto:jlhank80@...?Subject=%20Re%3AFindings%20by%20Reno%20scientists

%20confirmed%20by%20U%2ES%2E%20government> jlhank80@...

<jlhank80> jlhank80

Mon Aug 16, 2010 11:25 pm (PDT)

<http://www.rgj.com/article/20100816/NEWS/100816069/1321>

http://www.rgj.com/article/20100816/NEWS/100816069/1321

Findings by Reno scientists confirmed by U.S. government

LENITA POWERS • <mailto:lpowers%40rgj.com> lpowers@... • August 16,

2010

Two Reno scientists, who last year discovered a new infectious human

retrovirus they linked to Chronic Fatigue Syndrome, said Monday that their

findings have been replicated and confirmed by the U.S. Food and Drug

Administration.

Dr. Judy Mikovits, one of the lead researchers with the Whittemore

Institute for Neuro-Immune Disease in Reno, said the FDA's review of their

findings is scheduled to be published in September.

" There has been an issue over whether anybody could replicate our study, and

it will not only confirm our findings but extend our findings, which is

really exciting for us, " she said.

Mikovits said they also have new, unpublished data concerning the

retrovirus, XMRV, that could lead to treatment of Chronic Fatigue Syndrome.

" We have immune system profiles and we can tell by the immune system how the

XMRV is doing the damage, " she said. " So we could have a diagnostic test to

follow clinical treatment and show that people's immune systems go back to

normal. That's the latest data that's really amazing. That's what we're

after. "

That data will be published by the end of the year, probably in a clinical

immunology journal, she said.

Lombardi said clinical trials could begin soon at the Whittemore

Institute, which is relocating from its tiny laboratory on the University of

Nevada, Reno campus to the university's newly opened Center for Molecular

Medicine.

" Actually, we already have been contacted by people who are sending us

tests, perceiving that they may be asked to be part of the clinical trials, "

he said.

" I think once the (FDA) paper comes out and once the controversy is put to

rest, the pharmaceutical companies will realize that this is some very

low-hanging fruit for them to make the next transition, " said Lombardi.

" There are so many drugs that have been developed for HIV, and it's a

retrovirus. So there's probably a ton of HIV drugs that they can go back and

re-screen that could be used. "

There also are three published drugs that work against XMRV, Mikovits said.

" We totally expect at least one clinical treatment trial before the end of

the year, " she said. " That is our goal and that's what this new facility is

for. "